Daiwa Securities Group Inc. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4
-33.3%
8770.0%0.00%
Q2 2023$6
+20.0%
8770.0%0.00%
Q1 2023$5
+25.0%
877
+49.7%
0.00%
Q4 2022$4
-99.9%
5860.0%0.00%
Q3 2022$6,0000.0%5860.0%0.00%
Q2 2022$6,000
-25.0%
586
+27.9%
0.00%
Q1 2022$8,000
-11.1%
4580.0%0.00%
Q4 2021$9,000
-30.8%
458
-13.7%
0.00%
Q3 2021$13,000
+62.5%
531
+82.5%
0.00%
Q2 2021$8,000
-11.1%
2910.0%0.00%
Q1 2021$9,000
-30.8%
291
+5.4%
0.00%
Q4 2020$13,000
-51.9%
276
-66.3%
0.00%
Q3 2020$27,000
+28.6%
819
+15.0%
0.00%
Q2 2020$21,0000.0%7120.0%0.00%
Q1 2020$21,000
+5.0%
7120.0%0.00%
Q4 2019$20,000
+42.9%
712
-9.3%
0.00%
Q3 2019$14,000
-26.3%
7850.0%0.00%
Q2 2019$19,000
+171.4%
7850.0%0.00%
Q1 2019$7,000
+75.0%
785
+95.8%
0.00%
Q4 2018$4,000
-20.0%
4010.0%0.00%
Q3 2018$5,0000.0%4010.0%0.00%
Q2 2018$5,000
-28.6%
4010.0%0.00%
Q1 2018$7,0004010.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,222,701$25,005,0008.92%
Broadfin Capital, LLC 4,894,361$55,062,0008.10%
GREAT POINT PARTNERS LLC 3,496,340$39,334,0006.13%
FRAZIER MANAGEMENT LLC 2,188,331$24,619,0004.51%
Prosight Management, LP 715,317$8,047,0004.49%
Avoro Capital Advisors LLC 8,662,720$97,456,0004.48%
QVT Financial LP 821,361$8,748,0002.26%
Perceptive Advisors 7,290,199$82,014,0002.19%
Rhenman & Partners Asset Management AB 1,290,495$14,518,0001.46%
EMORY UNIVERSITY 185,915$2,092,0001.37%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders